sesamin has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, M; Karrar, E; Liu, R; Shi, L; Wang, X | 1 |
| Huo, J; Yan, Y; Yang, Y; Yu, J | 1 |
| Choi, CY; Han, EH; Jeong, GS; Jeong, HG; Jin, SW; Ki Lee, S; Kim, HS; Kim, ND; Lee, GH; Lee, SY; Pham, TH | 1 |
| Cheng, Y; Han, B; Hu, S; Luo, X; Yang, H; Yu, Y; Zhang, J; Zhang, R | 1 |
4 other study(ies) available for sesamin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Comparative effects of sesame lignans (sesamin, sesamolin, and sesamol) on oxidative stress and lipid metabolism in steatosis HepG2 cells.
Topics: Benzodioxoles; Cholesterol; Dioxoles; Hep G2 Cells; Humans; Lignans; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenols; Sesame Oil; Sesamum | 2022 |
Sesamin Attenuates Obesity-Associated Nonalcoholic Steatohepatitis in High-Fat and High-Fructose Diet-Fed Mice.
Topics: Animals; Diet; Diet, High-Fat; Dioxoles; Fructose; Lignans; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Protein Serine-Threonine Kinases | 2023 |
Sesamin ameliorates lipotoxicity and lipid accumulation through the activation of the estrogen receptor alpha signaling pathway.
Topics: AMP-Activated Protein Kinases; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Estrogen Receptor alpha; Hep G2 Cells; Humans; Lignans; Lipid Metabolism; Liver; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Palmitates; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2023 |
Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytochrome P-450 CYP2E1; Diet, High-Fat; Dioxoles; Dyslipidemias; Hypolipidemic Agents; Inflammation; Interleukin-6; Lignans; Lipid Metabolism; Lipids; Lipogenesis; Liver; Liver X Receptors; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytotherapy; Plant Extracts; PPAR alpha; Rats, Sprague-Dawley; Sesamum; Tumor Necrosis Factor-alpha | 2016 |